Singapore: +65-85097465 | India: +91-40-42023318
  U.S / Canada Toll Free: +1-866-259-4781
  Zimbabwe: +263-735539685, 773876488


Clinical Trial News

A new way to kill melanoma skin cancers

Scientists are adding new DNA to the cells of patients in a world-first treatment to attack and kill melanoma skin cancers.

Study finds that daily Cognizin citicoline oral supplement improves attention in adolescent males

Results of a double-blind, placebo-controlled, human clinical trial showed that nearly one month of oral supplementation with Cognizin® citicoline resulted in improved attention and motor...

First ever successful field testing of Ebola vaccine reported

The vaccine rVSV-ZEBOV has proven to be successful at halting the spread of the Ebola virus in ongoing field tests conducted in Guinea.

Penn bioethicists call for end to 'pay-to-play' clinical research

Journal article argues that charging people to participate in research is harmfulCharging people to participate in research studies is likely to undermine the fundamental ethical basis of...

New study data show reduced intracranial pressure using therapeutic hypothermia

Results from a European clinical trial comparing therapeutic hypothermia to standard treatment for patients with elevated intracranial pressure (ICP) as a result of severe traumatic brain injury...

UCB announces Phase 3 clinical trial program for epratuzumab in Systemic Lupus Erythematosus did not meet primary endpoint

UCB has announced that the two EMBODY™ Phase 3 clinical studies for epratuzumab in Systemic Lupus Erythematosus (SLE) did not meet their primary clinical efficacy endpoints in either dose in...

Cambridge researchers and pharma in innovative new consortium to develop and study early stage drugs

An innovative new Consortium will act as a 'match-making' service between pharmaceutical companies and researchers in Cambridge with the aim of developing and studying precision medicines for some...

Race & institutional factors play an important role in pharmacogenomic trial participation

White patients and larger well-supported institutions are more likely to have higher participation rates in pharmacogenomic trialsCancer therapy has evolved from a "one-size-fits-all" type of...

James Lind Institute Newsletter
James Lind Institute Linkedin
James Lind Institute RSS
James Lind Institute Email Update
James Lind Institute Blog
James Lind Institute Facebook